Codi Gharagouzloo, a distinguished graduate of Northeastern University, has made notable advancements in the field of medical imaging. His transition from a dedicated physicist to a forward-thinking innovator has resulted in the development of quantum-based MRI technology that holds the potential for early disease detection.
In 2011, Gharagouzloo enrolled in Northeastern University’s Ph.D. program with a strong commitment to finding a cure for cancer. Initially concentrating on nanoparticle-based cancer treatment, he soon recognized that specific targeting based on discoveries in molecular biology was crucial to success. This realization prompted a shift in focus to MRI technology, with the goal of transforming the way radiologists receive and interpret medical imaging data.
Over the span of 12 years, Gharagouzloo has meticulously cultivated his pioneering technology, which is currently in the initial stages of commercialization. He attributes much of his success to the aid and resources provided by Northeastern, particularly the accessibility to an MRI scanner, which played a vital role in the development of his groundbreaking innovation.
In 2018, Gharagouzloo, alongside his wife, Valerie, and investor Mike Lawson, established Imaginostics. The company has garnered widespread recognition, earning a finalist spot in Hello Tomorrow, a esteemed competition for deep tech startups. The breakthrough technology, known as “QUTE-CE MRI,” is a non-invasive imaging platform that significantly enhances the quality of MRI scans, offering superior diagnostic capabilities without the use of toxic contrast agents.
Valerie, an esteemed attorney from New York, now serves as the chief operating officer of Imaginostics. She is of the belief that their technology has the potential to revolutionize the healthcare industry by providing early detection of complex diseases years before the onset of symptoms. Not only does this afford patients a greater chance at early treatment, but it also offers valuable data for pharmaceutical companies to develop more effective treatments.
The Gharagouzloos’ pioneering MRI technology is positioned to transform the landscape of medical diagnostics, offering optimism and advancement in the early detection and treatment of diseases. With the continuous backing of institutions like Northeastern University, their groundbreaking work is poised to redefine the future of medical imaging.